Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
April 3, 2018
Reata to Present Preclinical Data on RTA 1701, a Novel RORγt Inverse Agonist, at Upcoming Immunology Conference
IRVING, Texas, April 03, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA) (Reata or Company), a clinical-stage biopharmaceutical company, today announced the upcoming presentation of ...
April 3, 2018
Aptose to Present at the H.C. Wainwright Annual Global Life Sciences Conference
SAN DIEGO and TORONTO, April 03, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (APTO) (APS.TO), a clinical-stage company developing highly differentiated ...
April 3, 2018
HTG Announces New Patent for Its Technology Issued in Japan
TUCSON, Ariz., April 03, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today ...
April 3, 2018
ARMO BioSciences to Participate in Panel on Cytokines at 8th Annual Cancer Immunotherapy Conference
REDWOOD CITY, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- ARMO BioSciences, Inc. (ARMO), a late-stage immuno-oncology company, today announced that Martin Oft, M.D., Senior Vice ...
April 3, 2018
Aeglea BioTherapeutics to Present New Phase 1/2 Trial Results in Arginase 1 Deficiency at the 2018 ACMG Annual Clinical Genetics Meeting
AUSTIN, Texas, April 03, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
April 3, 2018
Intec Pharma Ltd. to Host Key Opinion Leader Luncheon on Novel Drug Delivery Solutions in the Treatment of Parkinson's Disease
JERUSALEM, April 3, 2018 /PRNewswire/ --Intec Pharma Ltd. (NTEC) (NTEC.TA), a clinical stage biopharmaceutical company focused on developing pharmaceutical therapies based on its proprietary Accordion ...
April 3, 2018
Bellerophon Therapeutics to Provide Corporate Update at H.C. Wainwright Annual Global Life Sciences Conference
WARREN, N.J., April 03, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that Fabian Tenenbaum, ...
April 3, 2018
Preliminary Data from Phase 3 VISTA Trial in Bladder Cancer to Be Presented in a Plenary Session at American Urological Association Annual Meeting
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics, Inc. (EBIO), a late-stage clinical company developing next-generation antibody-drug conjugate (ADC) therapies for the treatment of cancer, today announced that preliminary ...
April 3, 2018
UroGen Pharma Announces Presentation of Results from Interim Analysis of Pivotal Phase 3 OLYMPUS Trial of UGN-101 (MitoGel™) for Non-Surgical Treatment of Upper Tract Urothelial Cancer (UTUC)
RA’ANANA, Israel and NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
April 2, 2018
TherapeuticsMD Announces Expansion of Board of Directors
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (TXMD), an innovative women’s healthcare company, today announced the appointment of Jane F. Barlow, M.D., M.B.A., M.P.H. as an independent ...
April 2, 2018
STRATA Skin Sciences Reports Fourth Quarter and Fiscal Year 2017 Financial Results
HORSHAM, Pa., April 02, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, ...
April 2, 2018
STRATA Skin Sciences Announces $17 Million Equity Financing led by Accelmed Growth Partners; Appointment of Industry Veteran as Interim CEO
HORSHAM, Pa., April 02, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, ...
April 2, 2018
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
REDWOOD CITY, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of ...
April 2, 2018
Eiger BioPharmaceuticals to Participate in Conferences in April
PALO ALTO, Calif., April 2, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today ...
April 2, 2018
ARMO BioSciences Reports FY 2017 Financial Results
REDWOOD CITY, Calif., April 02, 2018 (GLOBE NEWSWIRE) --  ARMO BioSciences, Inc. (ARMO), a late-stage immuno-oncology company, today announced its financial results for the fiscal ...
April 2, 2018
BioLife Solutions Announces Preliminary First Quarter 2018 Revenue of $3.8 Million, up 61% Year-over-Year and 22% Sequentially
BOTHELL, Wash., April 2, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS) ("BioLife"), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic ...
April 2, 2018
Albireo to Present at H.C. Wainwright Global Life Sciences Conference
BOSTON, April 02, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
April 2, 2018
Aeglea BioTherapeutics Doses First Small Cell Lung Cancer Patients with Pegzilarginase in Both Monotherapy and KEYTRUDA® (Pembrolizumab) Combination Trials
AUSTIN, Texas, April 02, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
April 2, 2018
Data Highlighting Advaxis’ ADXS-PSA Accepted as Poster Presentation at the American Society of Clinical Oncology Annual Meeting
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, announces that The American Society of Clinical ...
March 28, 2018
TRACON Pharmaceuticals Announces $38.7 Million Private Placement
SAN DIEGO, March 23, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...
Page 74 of 138